Amneal Pharmaceuticals Inc (NASDAQ: AMRX) started the day on Wednesday, with a price increase of 1.95% at $8.37, before settling in for the price of $8.21 at the close. Taking a more long-term approach, AMRX posted a 52-week range of $6.32-$9.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 32.70%. Meanwhile, its Annual Earning per share during the time was 32.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 21.55%. This publicly-traded company’s shares outstanding now amounts to $313.38 million, simultaneously with a float of $143.72 million. The organization now has a market capitalization sitting at $2.62 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.62, while the 200-day Moving Average is $8.12.
Amneal Pharmaceuticals Inc (AMRX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. Amneal Pharmaceuticals Inc’s current insider ownership accounts for 54.15%, in contrast to 39.72% institutional ownership. According to the most recent insider trade that took place on Jun 16 ’25, this organization’s Director sold 94,906 shares at the rate of 8.02, making the entire transaction reach 761,146 in total value, affecting insider ownership by 1,609,144. Preceding that transaction, on Jun 10 ’25, Company’s Director sold 56,426 for 8.02, making the whole transaction’s value amount to 452,537. This particular insider is now the holder of 1,704,050 in total.
Amneal Pharmaceuticals Inc (AMRX) Earnings and Revenue Records
Amneal Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 21.55% and is forecasted to reach 0.83 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 20.97% through the next 5 years, which can be compared against the 32.70% growth it accomplished over the previous five years trading on the market.
Amneal Pharmaceuticals Inc (NASDAQ: AMRX) Trading Performance Indicators
Let’s observe the current performance indicators for Amneal Pharmaceuticals Inc (AMRX). It’s Quick Ratio in the last reported quarter now stands at 0.84. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.93. Similarly, its price to free cash flow for trailing twelve months is now 10.82.
In the same vein, AMRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.04, a figure that is expected to reach 0.17 in the next quarter, and analysts are predicting that it will be 0.83 at the market close of one year from today.
Technical Analysis of Amneal Pharmaceuticals Inc (AMRX)
If we take a close look at the recent performances of Amneal Pharmaceuticals Inc (NASDAQ: AMRX), its last 5-days Average volume was 2.15 million that shows progress from its year to date volume of 1.74 million. During the previous 9 days, stock’s Stochastic %D was recorded 79.37% While, its Average True Range was 0.24.
Raw Stochastic average of Amneal Pharmaceuticals Inc (AMRX) in the period of the previous 100 days is set at 68.15%, which indicates a major fall in contrast to 93.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 31.40% that was lower than 37.70% volatility it exhibited in the past 100-days period.
